General Information of the Compound
Compound ID
CP0543477
Compound Name
1-benzyl-5-ethyl-N-(2-piperidin-1-ylethyl)benzimidazol-2-amine
    Show/Hide
Structure
Formula
C23H30N4
Molecular Weight
362.521
Canonical SMILES
CCc1ccc2n(Cc3ccccc3)c(NCCN3CCCCC3)nc2c1
    Show/Hide
InChI
InChI=1S/C23H30N4/c1-2-19-11-12-22-21(17-19)25-23(24-13-16-26-14-7-4-8-15-26)27(22)18-20-9-5-3-6-10-20/h3,5-6,9-12,17H,2,4,7-8,13-16,18H2,1H3,(H,24,25)
    Show/Hide
InChIKey
UOJLOQLRRSDLQG-UHFFFAOYSA-N
Physicochemical Property
logP
4.5448
Rotatable Bonds
7
Heavy Atom Count
27
Polar Areas
33.09
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
27

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 168283849
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT05452, Short transient receptor potential channel 5
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 3350 nM
   TI
   LI
   LO
   TS